The cell polarity protein Scrib functions as a tumor suppressor in liver cancer

Shweta Kapil, Bal Krishan Sharma, Mallikarjun Patil, Sawsan Elattar, Jinling Yuan, Steven X. Hou, Ravindra Kolhe, Satyanarayana Ande

Oncotarget · 2017 · 38 citations · 40 references

DOIFull text

Open access

Concepts

Abstract

// Shweta Kapil 1, * , Bal Krishan Sharma 1, * , Mallikarjun Patil 1, * , Sawsan Elattar 1 , Jinling Yuan 1 , Steven X. Hou 2 , Ravindra Kolhe 3 , Ande Satyanarayana 1 1 Department of Biochemistry and Molecular Biology, Molecular Oncology & Biomarkers Program, Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA 2 Stem Cell Regulation and Animal Aging Section, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA 3 Department of Pathology, Augusta University, Augusta, GA 30912, USA * These authors contributed equally to this work Correspondence to: Ande Satyanarayana, email: sande@augusta.edu Keywords: HCC, nuclear localization, ERK, hippo signaling, Yap1 Received: January 13, 2017      Accepted: February 15, 2017      Published: February 24, 2017 ABSTRACT Scrib is a membrane protein that is involved in the maintenance of apical-basal cell polarity of the epithelial tissues. However, Scrib has also been shown to be mislocalized to the cytoplasm in breast and prostate cancer. Here, for the first time, we report that Scrib not only translocates to the cytoplasm but also to the nucleus in hepatocellular carcinoma (HCC) cells, and in mouse and human liver tumor samples. We demonstrate that Scrib overexpression suppresses the growth of HCC cells in vitro, and Scrib deficiency enhances liver tumor growth in vivo. At the molecular level, we have identified the existence of a positive feed-back loop between Yap1 and c-Myc in HCC cells, which Scrib disrupts by simultaneously regulating the MAPK/ERK and Hippo signaling pathways. Overall, Scrib inhibits liver cancer cell proliferation by suppressing the expression of three oncogenes, Yap1, c-Myc and cyclin D1, thereby functioning as a tumor suppressor in liver cancer.

References

40